In this context, the application of substance P (SP), an eleven amino acid peptide of the tachykinin family [22] would be a further promising approach, as it may treat dopaminergic deficiency after stroke via multiple mechanisms: SP exerts a protective effect against excitotoxic damage [23] and deprivation of trophic factors [24]. Here, TAC1 is linked to stroke disorder.